ultrafocus dual energy x ray absorptiometry faxitron quantification Search Results


ultrafocus dual energy x ray absorptiometry faxitron quantification  (Faxitron Bioptics)
86
Faxitron Bioptics ultrafocus dual energy x ray absorptiometry faxitron quantification
DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
Ultrafocus Dual Energy X Ray Absorptiometry Faxitron Quantification, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/absorptiometry+dual+energy+ray+x/pmc13153612-85-27-30
Average 86 stars, based on 1 article reviews
ultrafocus dual energy x ray absorptiometry faxitron quantification - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
dexa  (Faxitron Bioptics)
86
Faxitron Bioptics dexa
DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
Dexa, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/dexa/pm41723149-247-19-27
Average 86 stars, based on 1 article reviews
dexa - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
ultrafocus dxa instrument  (Faxitron Bioptics)
86
Faxitron Bioptics ultrafocus dxa instrument
DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
Ultrafocus Dxa Instrument, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/dxa+faxitron+ultrafocus/pm42045445-393-19-21
Average 86 stars, based on 1 article reviews
ultrafocus dxa instrument - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
mct40  (SCANCO USA INC)
90
SCANCO USA INC mct40
DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
Mct40, supplied by SCANCO USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/micro+ct/10__7554_slash_elife__49631-295-48-51
Average 90 stars, based on 1 article reviews
mct40 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.

Journal: Blood Neoplasia

Article Title: Microenvironmentally derived fatty acid–binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma ∗

doi: 10.1016/j.bneo.2026.100229

Figure Lengend Snippet: DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.

Article Snippet: Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10).

Techniques: Injection, Comparison